© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
Enhancing lives and empowering patients by closing the existing gap from initial diagnosis to immediate and expanded access to advanced treatment, clinical trials, and critical care
May 13, 2020
The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
March 29, 2016
May 28, 2015
2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).
FDA Approves Lorbrena as First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer
Imbruvica Plus Novel Agent May Improve Progression-Free Survival in Chronic Lymphocytic Leukemia
How Caregivers Can Become an Active Part of the Cancer Care Team
Strict Cleaning Protocols Induce Limited Traces of Virus That Causes COVID-19 in Cancer Centers